Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASUS: Abatacept in Seronegative Undifferentiated Arthritis Study
2008-004878-41Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Sep 2009
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of abatacept in undifferentiated arthritis (UA), sponsored by University of Leeds. Primary endpoint: Primary endpoint at 6 months. Started Sep 2009; status: completed.
02
Drugs
abatacept
03
Conditions
undifferentiated arthritis (UA)
Beyond the preview
Go deeper on 2008-004878-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004878-41.